In contrast, survivin overexpression in MOLM‐14/CRISPR/survivin cells led to increased AML induction with 4/5 mice having detectible disease in the bone marrow and mean levels of 5.3% blast involvement (Figure 5C, D). Here, BIRC5 is linked to acute myeloid leukemia.